Human papillomavirus infection among 100 oesophageal cancer cases in the People's Republic of China

Human papillomavirus infection among 100 oesophageal cancer cases in the People’s Republic of China Min Dai, Wei-dong Zhang, Gary M. Clifford, Tarik Gheit, Bao-chang He, Kristina M. Michael, Tim Waterboer, Pierre Hainaut, Massimo Tommasino and Silvia Franceschi* International Agency for Research on Cancer, Lyon, France Department of Epidemiology, Zhengzhou University, Zhengzhou, China Department of Epidemiology, Fujian Medical University, Fuzhou, China Infection and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg, Germany

[1]  C. Abnet,et al.  No association between HPV infection and the neoplastic progression of esophageal squamous cell carcinoma: Result from a cross‐sectional study in a high‐risk region of China , 2006, International journal of cancer.

[2]  T. Fears,et al.  Human papillomavirus serology and the risk of esophageal and gastric cancers: Results from a cohort in a high‐risk region in China , 2006, International journal of cancer.

[3]  S. Franceschi,et al.  Development of a Sensitive and Specific Assay Combining Multiplex PCR and DNA Microarray Primer Extension To Detect High-Risk Mucosal Human Papillomavirus Types , 2006, Journal of Clinical Microbiology.

[4]  Markus F Templin,et al.  Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. , 2005, Clinical chemistry.

[5]  Y. Ke,et al.  LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China. , 2005, Carcinogenesis.

[6]  S. Franceschi,et al.  Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. , 2004, The Journal of infectious diseases.

[7]  H. Stein,et al.  Esophageal squamous cell cancer in patients with head and neck cancer: Prevalence of human papillomavirus DNA sequences , 2004, International journal of cancer.

[8]  S. Franceschi,et al.  Human Papillomavirus Type 16 and TP53 Mutation in Oral Cancer , 2004, Cancer Research.

[9]  S. Franceschi,et al.  Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. , 2003, Journal of the National Cancer Institute.

[10]  K. Shah,et al.  Chapter 9: Role of mucosal human papillomavirus in nongenital cancers. , 2003, Journal of the National Cancer Institute. Monographs.

[11]  J. Dillner,et al.  Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites , 2003, British Journal of Cancer.

[12]  K. Syrjänen,et al.  HPV infections and oesophageal cancer , 2002, Journal of clinical pathology.

[13]  C. Harris,et al.  The IARC TP53 database: New online mutation analysis and recommendations to users , 2002, Human mutation.

[14]  G. Snow,et al.  Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas , 2001, International journal of cancer.

[15]  Y. Ke,et al.  Human papillomavirus type 16 is an important infectious factor in the high incidence of esophageal cancer in Anyang area of China. , 2001, Carcinogenesis.

[16]  E. de Villiers,et al.  An interlaboratory study to determine the presence of human papillomavirus DNA in esophageal carcinoma from China , 1999, International journal of cancer.

[17]  S. Tsao,et al.  Presence of human papillomavirus in esophageal squamous cell carcinomas of Hong Kong Chinese and its relationship with p53 gene mutation. , 1997, Human pathology.

[18]  M. Sur,et al.  The role of the human papilloma virus in esophageal cancer , 1998, Pathology.